Serum myostatin levels are positively associated with diabetic retinopathy in individuals with type 2 diabetes mellitus.
Diabetes mellitus, type 2
Diabetic retinopathy
Myostatin
Journal
Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
27
02
2020
revised:
14
04
2020
accepted:
14
04
2020
pubmed:
2
5
2020
medline:
24
11
2021
entrez:
2
5
2020
Statut:
ppublish
Résumé
To examine the relationship between serum myostatin levels and diabetic retinopathy in individuals with type 2 diabetes mellitus (DM). This cross-sectional study evaluated 246 individuals with type 2 DM. Analysis of covariance was performed after adjusting for confounders. A logistic regression model was used to evaluate the relationship between serum myostatin levels and diabetic retinopathy. Serum myostatin levels were significantly higher in individuals with diabetic retinopathy than in those without. After adjusting for other covariates, the mean serum myostatin levels were significantly different according to the severity of retinopathy (without diabetic retinopathy, 2234 pg/mL; non-proliferative diabetic retinopathy, 2698 pg/mL; and proliferative diabetic retinopathy, 3076 pg/mL; p for trend = 0.004). The multivariate analysis showed that serum myostatin levels were significantly associated with diabetic retinopathy (odds ratio for every 1 standard deviation-increase in logarithmic value, 1.77; 95% confidence interval: 1.21-2.59; p = 0.003). Serum myostatin levels were positively associated with diabetic retinopathy in individuals with type 2 DM.
Identifiants
pubmed: 32354624
pii: S1056-8727(20)30344-5
doi: 10.1016/j.jdiacomp.2020.107592
pii:
doi:
Substances chimiques
Myostatin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
107592Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.